NME2 and renal carcinoma: Most of the genes have usually been investigated as prognostic biomarkers in renal cancer, and RPS18, RPL30, NME2, and RPS25 usually have been investigated as unfavorable predictors, while GAB2 has been reported as favorable predictor in renal cancer [30].